WNT5A and prostate carcinoma: Furthermore, Foxy-5, a peptide derived from the same region of Wnt5a as UM206, has been shown to reduce metastatic spread of prostate cancer cells, underscoring the pharmacological potency of Wnt5a fragments (22).